Strongyloides hyperinfection syndrome complicating (ectopic) cushing syndrome

Southern Medical Journal

Volumn 101, Issue 7, 2008, Pages 750-752

  Vadlamudi, Raja S ^a   Van Dort, Martin ^b   Barklow, Thomas ^b   Byrd Jr , Ryland P ^b   Moorman, Jonathan P ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Cushing syndrome; Ectopic ACTH; Hyperinfection syndrome; Lung cancer; Strongyloidiasis

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; IVERMECTIN; POTASSIUM; STEROID;

ADRENAL METASTASIS; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; AUTOPSY; CASE REPORT; CD4 LYMPHOCYTE COUNT; COMPUTER ASSISTED TOMOGRAPHY; CORTICOTROPIN BLOOD LEVEL; CUSHING SYNDROME; DEATH; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DISSEMINATED CANCER; EMERGENCY WARD; EOSINOPHILIA; FECES ANALYSIS; HEART ARREST; HEMOPTYSIS; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOKALEMIA; INTUBATION; LARVA; LUNG SMALL CELL CANCER; LYMPHOCYTOPENIA; MALE; MEDIASTINUM MASS; METABOLIC ALKALOSIS; METASTASIS; PAROXYSMAL DYSPNEA; SINUS ARRHYTHMIA; SPUTUM ANALYSIS; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; WEAKNESS; WHEEZING; FATALITY; LUNG INFECTION; LUNG TUMOR; PATHOPHYSIOLOGY;

AGED; CUSHING SYNDROME; FATAL OUTCOME; HUMANS; LUNG DISEASES, PARASITIC; LUNG NEOPLASMS; MALE; SMALL CELL LUNG CARCINOMA; STRONGYLOIDIASIS;

EID: 62849096087     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e31817a836e     Document Type: Article

References (12)

1. Concha R, Harrington W Jr, Rogers AI. Intestinal strongyloidiasis: recognition, management, and determinants of outcome. J Clin Gastroenterol 2005;39:203-211.
2. Cruz T, Reboucas G, Rocha H. Fatal strongyloidiasis in patients receiving corticosteroids. N Engl J Med 1966;275:1093-1096.
3. Siddiqui AA, Berk SL. Diagnosis of strongyloides stercoralis infection. Clin Infect Dis 2007;33:1040-1047.
4. Gotuzzo E, Terashima A, Alvarez H, et al. Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru. Am J Trop Med Hyg 1999;60:146-149.
5. Singh S. Human strongyloidiasis in AIDS era: its zoonotic importance. J Assoc Physicians India 2002;50:415-422.
6. Cummins RO, Suratt PM, Horwitz DA. Disseminated strongyloides stercoralis infection. Association with ectopic ACTH syndrome and depressed cell-mediated immunity. Arch Intern Med 1978;138:1005-1006.
7. Vadlamudi RS, Chi DS, Krishnaswamy G. Intestinal strongyloidiasis and hyperinfection syndrome. Clin Mol Allergy 2006;4:8.
8. Siddiqui AA, Genta RM, Berk SL. Strongyloides stercoralis, in Blaser, Smith, Ravdin, Greenberg, Guerrant (eds): Infections of Gastrointestinal Tract. Philadelphia, Lipponcott Wiliams & Wilkins, 2002, ed 2, pp1113- 1126.
9. Gill GV, Welch E, Bailey JW, et al. Chronic strongyloides stercoralis infection in former British far east prisoners of war. QJM 2004;97:789- 795.
10. Huaman MC, Sato Y, Aguilar JL, et al. Gelatin particle indirect agglutination and enzyme-linked immunosorbent assay for diagnosis of strongyloidiasis using Strongyloides venezuelensis antigen. Trans R Soc Trop Med Hyg 2003;97:535-538.
11. Uparanukraw P, Phongsri S, Morakote N. Fluctuations of larval excretion in Strongyloides stercoralis infection. Am J Trop Med Hyg 1999; 60:967-973.
12. Gann PH, Neva FA, Gam AA. A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J Infect Dis 1994;169:1076-1079.